FDA Orange Book · active-ingredient family
Hexaminolevulinate hydrochloride
Hexaminolevulinate hydrochloride is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:CYSVIEW KIT · NDA 022555
1
Brand (NDA)
0
Generics (ANDA)
3
Listed patents
0
Exclusivity periods
Brand (NDA) products · for solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CYSVIEW KITRLD | PHOTOCURE ASA | NDA 022555 | — | May 28, 2010 |
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10556010 | Dec 19, 2036 | in 10 yr 8 mo | U-2250 |
| 11311620 | Dec 19, 2036 | in 10 yr 8 mo | U-2250 |
| 11235168 | Jan 04, 2038 | in 11 yr 9 mo | U-2250 |
Hexaminolevulinate hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
